share_log

德琪醫藥-B:自願公告 德琪醫藥同類首款新藥塞利尼索片(希維奧)成功納入2023年版國家醫保藥品目錄

ANTENGENE-B: VOLUNTARY ANNOUNCEMENT SELINEXOR (XPOVIO), ANTENGENE''S FIRST-IN-CLASS NEW DRUG, SUCCESSFULLY INCLUDED IN 2023 NATIONAL REIMBURSEMENT DRUG LIST

香港交易所 ·  Dec 13, 2023 17:50
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more